Correlation Engine 2.0
Clear Search sequence regions


  • ANGII (1)
  • aorta (1)
  • calcium (2)
  • cardiovascular diseases (1)
  • CD25 (1)
  • cytokines (1)
  • DEL- 1 (11)
  • doca (1)
  • Edil3 (1)
  • elastin (1)
  • factor (1)
  • factor ii (1)
  • FoxP3 (1)
  • human (1)
  • il 10 (1)
  • integrin (4)
  • left ventricular function (1)
  • mice (6)
  • MMP2 (1)
  • therapies (1)
  • Sizes of these terms reflect their relevance to your search.

    The causative role of inflammation in hypertension-related cardiovascular diseases is evident and calls for development of specific immunomodulatory therapies. We tested the therapeutic efficacy and mechanisms of action of developmental endothelial locus-1 (DEL-1), an endogenous antiinflammatory factor, in angiotensin II- (ANGII-) and deoxycorticosterone acetate-salt-induced (DOCA-salt-induced) cardiovascular organ damage and hypertension. By using mice with endothelial overexpression of DEL-1 (EC-Del1 mice) and performing preventive and interventional studies by injecting recombinant DEL-1 in mice, we showed that DEL-1 improved endothelial function and abrogated aortic adventitial fibrosis, medial thickening, and loss of elastin. DEL-1 also protected the mice from cardiac concentric hypertrophy and interstitial and perivascular coronary fibrosis and improved left ventricular function and myocardial coronary perfusion. DEL-1 prevented aortic stiffness and abolished the progression of hypertension. Mechanistically, DEL-1 acted by inhibiting αvβ3 integrin-dependent activation of pro-MMP2 in mice and in human isolated aorta. Moreover, DEL-1 stabilized αvβ3 integrin-dependent CD25+FoxP3+ Treg numbers and IL-10 levels, which were associated with decreased recruitment of inflammatory cells and reduced production of proinflammatory cytokines in cardiovascular organs. The demonstrated effects and immune-modulating mechanisms of DEL-1 in abrogation of cardiovascular remodeling and progression of hypertension identify DEL-1 as a potential therapeutic factor.

    Citation

    Theresa Failer, Michael Amponsah-Offeh, Aleš Neuwirth, Ioannis Kourtzelis, Pallavi Subramanian, Peter Mirtschink, Mirko Peitzsch, Klaus Matschke, Sems M Tugtekin, Tetsuhiro Kajikawa, Xiaofei Li, Anne Steglich, Florian Gembardt, Annika C Wegner, Christian Hugo, George Hajishengallis, Triantafyllos Chavakis, Andreas Deussen, Vladimir Todorov, Irakli Kopaliani. Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation. The Journal of clinical investigation. 2022 Mar 15;132(6)

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35133978

    View Full Text